Literature DB >> 1321167

Role of coproantibody in clinical protection of children during reinfection with rotavirus.

B S Coulson1, K Grimwood, I L Hudson, G L Barnes, R F Bishop.   

Abstract

Rotavirus is the major cause of severe, dehydrating infantile gastroenteritis. Infection is limited to the gut, but the relative roles of serum and secretory copro-immunoglobulin A (IgA) in protection are unclear. Specific copro-IgA is predictive of duodenal antirotaviral IgA and correlates with virus-neutralizing coproantibody. Copro-IgA conversion is a more sensitive marker of rotavirus reinfection than seroconversion. We measured rotavirus reinfections by copro-IgA conversion prospectively in 35 children recruited at a time of severe rotavirus illness. The children were followed up longitudinally for 14 to 31 months to determine whether high coproantibody levels correlated with clinical protection against rotavirus disease. Ninety-four percent of the children experienced reinfection, and 38% developed persistent elevations in specific copro-IgA termed plateaus. Plateau children had a higher mean annual rate of rotavirus infection and a lower ratio of symptomatic to total number of rotavirus reinfections than did nonplateau children. The annual rates of rotavirus infection and disease were significantly higher outside the plateau than inside it in children experiencing antirotavirus copro-IgA plateaus. Frequent rotavirus infection of children appears to stimulate production of a specific copro-IgA plateau which correlates with protection against an excess of infection and symptomatic disease.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1321167      PMCID: PMC265363          DOI: 10.1128/jcm.30.7.1678-1684.1992

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  21 in total

1.  Epidemiology of rotavirus serotypes in Melbourne, Australia, from 1973 to 1989.

Authors:  R F Bishop; L E Unicomb; G L Barnes
Journal:  J Clin Microbiol       Date:  1991-05       Impact factor: 5.948

2.  Anamnestic response in fecal IgA antibody production after rotaviral infection of infants.

Authors:  H Yamaguchi; S Inouye; M Yamauchi; T Morishima; S Matsuno; S Isomura; S Suzuki
Journal:  J Infect Dis       Date:  1985-08       Impact factor: 5.226

3.  Rotaviral immunity in gnotobiotic calves: heterologous resistance to human virus induced by bovine virus.

Authors:  R G Wyatt; C A Mebus; R H Yolken; A R Kalica; H D James; A Z Kapikian; R M Chanock
Journal:  Science       Date:  1979-02-09       Impact factor: 47.728

4.  Variation in neutralization epitopes of human rotaviruses in relation to genomic RNA polymorphism.

Authors:  B S Coulson
Journal:  Virology       Date:  1987-08       Impact factor: 3.616

5.  Long-term follow-up of infants from birth for rotavirus antigen and antibody in the feces.

Authors:  O Nishio; Y Ishihara; S Isomura; H Inoue; S Inouye
Journal:  Acta Paediatr Jpn       Date:  1988-08

6.  Heterologous protection against rotavirus-induced disease in gnotobiotic piglets.

Authors:  R F Bishop; S R Tzipori; B S Coulson; L E Unicomb; M J Albert; G L Barnes
Journal:  J Clin Microbiol       Date:  1986-12       Impact factor: 5.948

7.  Group- and type-specific serologic response in infants and children with primary rotavirus infections and gastroenteritis caused by a strain of known serotype.

Authors:  G Gerna; A Sarasini; M Torsellini; D Torre; M Parea; M Battaglia
Journal:  J Infect Dis       Date:  1990-06       Impact factor: 5.226

8.  Comparison of serum and mucosal antibody responses following severe acute rotavirus gastroenteritis in young children.

Authors:  K Grimwood; J C Lund; B S Coulson; I L Hudson; R F Bishop; G L Barnes
Journal:  J Clin Microbiol       Date:  1988-04       Impact factor: 5.948

9.  Clinical immunity after neonatal rotavirus infection. A prospective longitudinal study in young children.

Authors:  R F Bishop; G L Barnes; E Cipriani; J S Lund
Journal:  N Engl J Med       Date:  1983-07-14       Impact factor: 91.245

10.  Protective effect of naturally acquired homotypic and heterotypic rotavirus antibodies.

Authors:  S Chiba; T Yokoyama; S Nakata; Y Morita; T Urasawa; K Taniguchi; S Urasawa; T Nakao
Journal:  Lancet       Date:  1986-08-23       Impact factor: 79.321

View more
  51 in total

1.  Rotavirus-specific T-cell responses in young prospectively followed-up children.

Authors:  M Mäkelä; J Marttila; O Simell; J Ilonen
Journal:  Clin Exp Immunol       Date:  2004-07       Impact factor: 4.330

2.  Protein Malnutrition Alters Tryptophan and Angiotensin-Converting Enzyme 2 Homeostasis and Adaptive Immune Responses in Human Rotavirus-Infected Gnotobiotic Pigs with Human Infant Fecal Microbiota Transplant.

Authors:  David D Fischer; Sukumar Kandasamy; Francine C Paim; Stephanie N Langel; Moyasar A Alhamo; Lulu Shao; Juliet Chepngeno; Ayako Miyazaki; Huang-Chi Huang; Anand Kumar; Gireesh Rajashekara; Linda J Saif; Anastasia N Vlasova
Journal:  Clin Vaccine Immunol       Date:  2017-08-04

3.  Serum IgG mediates mucosal immunity against rotavirus infection.

Authors:  Larry E Westerman; Harold M McClure; Baoming Jiang; Jeffrey W Almond; Roger I Glass
Journal:  Proc Natl Acad Sci U S A       Date:  2005-05-09       Impact factor: 11.205

Review 4.  Enteric infections, diarrhea, and their impact on function and development.

Authors:  William A Petri; Mark Miller; Henry J Binder; Myron M Levine; Rebecca Dillingham; Richard L Guerrant
Journal:  J Clin Invest       Date:  2008-04       Impact factor: 14.808

Review 5.  Immune responses to rotavirus infection and vaccination and associated correlates of protection.

Authors:  Ulrich Desselberger; Hans-Iko Huppertz
Journal:  J Infect Dis       Date:  2011-01-15       Impact factor: 5.226

6.  Human rotavirus-specific IgM Memory B cells have differential cloning efficiencies and switch capacities and play a role in antiviral immunity in vivo.

Authors:  Carlos F Narváez; Ningguo Feng; Camilo Vásquez; Adrish Sen; Juana Angel; Harry B Greenberg; Manuel A Franco
Journal:  J Virol       Date:  2012-08-01       Impact factor: 5.103

7.  Lymphotoxin alpha-deficient mice clear persistent rotavirus infection after local generation of mucosal IgA.

Authors:  Uri Lopatin; Sarah E Blutt; Margaret E Conner; Brian L Kelsall
Journal:  J Virol       Date:  2012-10-24       Impact factor: 5.103

Review 8.  Re-thinking the functions of IgA(+) plasma cells.

Authors:  Jennifer L Gommerman; Olga L Rojas; Jörg H Fritz
Journal:  Gut Microbes       Date:  2014

9.  Virus-specific intestinal IFN-gamma producing T cell responses induced by human rotavirus infection and vaccines are correlated with protection against rotavirus diarrhea in gnotobiotic pigs.

Authors:  Lijuan Yuan; Ke Wen; Marli S P Azevedo; Ana M Gonzalez; Wei Zhang; Linda J Saif
Journal:  Vaccine       Date:  2008-04-18       Impact factor: 3.641

10.  Protective immunity induced by oral immunization with a rotavirus DNA vaccine encapsulated in microparticles.

Authors:  S C Chen; D H Jones; E F Fynan; G H Farrar; J C Clegg; H B Greenberg; J E Herrmann
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.